Background: Acute kidney injury (AKI) is one of the serious postoperative complications in
INTRODUCTION
Acute kidney injury (AKI) in patients undergoing heart valve surgery is one of the serious postoperative complications associated with prolonged hospitalization, increased mortality as well as the occurrence of chronic kidney disease [1] [2] [3] . The diagnosis of AKI is based on two functional markers, an increase of serum creatinine and a reduction of urinary excretion. Predictors of perioperative AKI in patients undergoing heart surgery include preoperative creatinine level, end-stage renal disease, 2-2 phenotype of haptoglobin, advanced age, diabetes mellitus, congestive heart failure, generalized atherosclerosis, cardiovascular collapse, nitric oxide, cyanotic heart disease, duration of surgery and elevated postoperative lactate level [4] [5] [6] [7] [8] [9] . In patients with severe AKI, oliguria and fluid accumulation, renal replacement therapy is the basic method of treatment [10] . Hemodiafiltration seems to represent the gold standard in the field of replacement of renal function in patients undergoing heart valve surgery [11] [12] [13] .
Red cell distribution width (RDW) is a parameter that reflects the variability of the size of red blood cells (anisocytosis). Elevated RDW is a result of erythrocytes production dysfunction related to a deficiency of folic acid, iron, vitamin B12 or ongoing inflammation as well as increased destruction of erythrocytes e.g. in the course of hemolysis. Previous studies have indicated the predictive ability of RDW in various cardiovascular disorders [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Identifying risk factors for developing AKI and aggressive early intervention is extremely important to optimize outcomes in patients with heart valve disease. Therefore, the aim of the present study was to identify and evaluate selected biomarkers to predict AKI requiring renal replacement therapy in patients undergoing heart valve surgery.
METHODS
A prospective study was conducted on a group of consecutive patients with hemodynamically significant valvular heart disease (aortic stenosis, aortic regurgitation, mitral stenosis and/or mitral regurgitation) that qualified for cardiac surgery and subsequently underwent elective replacement or repair of a valve/valves. The exclusion criteria were: patients under 18 years of age, a lack of consent to participate in the study, hemolytic disease, blood transfusion before surgery in the last 3 months, active neoplastic diseases, autoimmune diseases, chronic inflammatory bowel and active endocarditis. One day prior to surgery a blood sample for biomarkers was collected from each patient. Full blood counts were measured from K2EDTA samples using a Sysmex K-4500 electronic counter. 
Statistical analysis
Statistical analysis was performed using the SAS version 9. 
DISCUSSION
Acute kidney injury requiring renal replacement therapy is a common and significant complication after heart valve surgery. The present study revealed that this complication was seen in 6% of patients following heart valve surgery. The aim of this study was the evaluation and identification of predictors perioperative AKI requiring renal replacement therapy in the early postoperative period in patients undergoing heart valve surgery. In the present work RDW remained an independent predictor of AKI requiring renal replacement therapy and death from all causes in patients with primary endpoint. RDW is an inexpensive, simple and widely accessible parameter designated for each patient during a standard blood test.
Predictive ability of the RDW in various cardiovascular disorders have been reported in numerous publications. However, information regarding the usefulness of RDW in patients undergoing heart valve surgery is very limited [14, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . The predictive power of the RDW for perioperative stroke and multiple organ dysfunction syndrome was previously demonstrated [17, 24] . According to available research, there are no reports describing the usefulness of RDW in anticipation of the renal replacement therapy in an early postoperative period in patients undergoing valve surgery. Zou et al [27] described that an elevated RDW might be an independent prognostic factor for the severity and poor prognosis of AKI in patients undergoing cardiac surgery. Moreover, available literature has shown that higher values of RDW are associated with worse prognosis in patients with AKI treated with continuous renal replacement therapy [28] . The pathophysiological mechanisms that explain the relationship between increased RDW values and a worse prognosis are not clear.
According to current knowledge, elevated RDW is the cause of impaired microcirculation.
The older erythrocytes gradually lose the ability to deform the cell membrane. This feature is very important during the squeezing of anucleate cells through the vessels of small diameter in organs such as the kidneys. The rigid and large erythrocytes observed in patients with elevated values, RDW cannot squeeze through the capillaries and thus impair blood flow through microcirculation leading to renal tissue ischemia [29] . On the other hand, some authors connect RDW with a patient's physiologic reserve -the ability of cells to defend against the strong stress of hypoxia [30] . The reserve is very important in such stressful situations such as heart valve surgery. Elevated RDW, meant to reflect a reduced physiological reserve, may explain the fact of a higher incidence of serious complications in the postoperative period, such as postoperative acute kidney injury.
CONCLUSIONS
Red cell distribution width is a parameter that reflects the variability of the size of red blood cells (anisocytosis). Elevated RDW is a result of erythrocytes production dysfunction related to a deficiency of folic acid, iron, vitamin B12 or ongoing inflammation as well as CBT -cardiopulmonary bypass time; CRP -C-reactive protein; GFR -glomerular filtration rate; LV EF -left ventricular ejection fraction; RDW -red cell distribution width (preoperative); RDW1 -red cell distribution width measured 48 h after surgery 
